Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ginsenosides supplement

An oral and herbal supplement containing sixteen ginsenosides derived from ginseng and including the ginsenoside monomers Rg3(R, S), Rh1(S, R), Rh2(R, S), Rk1, Rk3, Rg5, Rh3, Rh4, Rk2, aPPD(S, R) and aPPT(S, R), that may potentially be used to reduce fatigue. Ginseng contains a complex mixture of ginsenosides, and ginsenosides may have different mechanisms of actions and pharmacological activities due to their structural differences. They may have anti-inflammatory, antioxidant, and cortisol-modulating activities, modulate various metabolic pathways, and are believed to act on the central nervous system (CNS), which may enhance vital energy and result in anti-fatigue effects.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:ginsenosides capsule
Foreign brand name:Redsenol-1 Plus
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search